# K992286: Dermafreeze

- Pathway: 510(k) (Traditional)
- Applicant: Rhealm Pharmaceuticals, Inc.
- Decided: Jan 21, 2000 after 198 days
- Product code: MLY (Vapocoolant Device)
- Device class: U
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
No later device cites it as a predicate yet.
0 of 1 device in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. FDA’s file for it is a 510(k) statement, which names no predicate.

## Indications for use
DermaFreeze™ is a vapocoolant intended for topical application for the control of pain associated with minor surgical procedures (such as lancing boils, or incision and drainage of small abscesses), injections, and contusions.

Source page: https://510kreport.com/device/K992286
Methodology: https://510kreport.com/methodology